Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities throughout its top pharma services network to support customers in government, business and academia because they accelerate development and production of COVID-19 vaccines, treatments and other treatments. The business is now supporting over 200 jobs internationally.
<blockquote>“Even before the pandemic, the company was strategically increasing its manufacturing, research and development capabilities, in addition to providing critical products and solutions for treating cancer, genetic diseases and other serious health concerns. Today, these initiatives are proving to be decisive in enabling our response to COVID-19 in India. We are well-positioned to extend our end-to-end workflow solutions for COVID-19 and quickly ramp up testing infrastructure and vaccine research and manufacturing,” said <strong>Amit Chopra, managing director, India &amp; Middle East, Thermo Fisher Scientific.</strong></blockquote>
Thermo Fisher is also encouraging Multiple vaccine programs globally that are entering or in human clinical trials, supplying critical capacity and expertise which has accelerated growth and readiness .
<blockquote>“Our investments in building capacity and capabilities demonstrate our commitment to fulfill our mission to enable our customers to make the world healthier, cleaner and safer,” <strong>Amit added. </strong></blockquote>
The company has expanded capacity For clients that are developing new and present therapies, including promising anti-viral medication, to meet increased demand and enable biopharma customers to significantly compress timelines for delivery to patients.

In addition to its own work on COVID-19-related vaccines and Therapies, the company continues to ensure that patients experiencing clinical Trials continue to get the essential medicines they need. A"website to Patient" program, launched at the start of the pandemic, has guaranteed Clinical trial patients have uninterrupted access to life-saving Investigational drug shipments without needing to go to a clinic, among many Attempts to keep supply chain continuity during the pandemic.

<strong>About Thermo Fisher Scientific</strong>

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.For more information, please visit <span style="color: #ff6600;"><a style="color: #ff6600;" href="https://www.thermofisher.com/in/en/home.html">www.thermofisher.com.</a></span>